Delivery Order SPE2DB24D1205-SPE2DB24FCSBK
Award Date 6/17/24
Potential Completion Date 7/10/24
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,575.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the provision of 4564591389 - CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of June 4, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract, valued at $17,150.74, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CALQUENCE 100 MG TABLET 60S. The contract, valued at $8,871.74, is a Delivery Order issued by the Defense Logistics Agency (DLA) and has a firm fixed price. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,593.77 for the supply of CALQUENCE 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with a period of performance through February 25, 2025. This award is part of a larger Indefinite Delivery Contract valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Calquence 100 mg tablets over a period ending June 5, 2024. The $17,150.74 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services to the U.S. Department of Defense. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded a $8,575.36 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564437716 - CALQUENCE 100 MG TABLET 60S, with a completion date of May 20, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of 4564730978 - CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $25,726.08 and is a Firm Fixed Price Delivery Order that runs through June 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, involves the delivery of CALQUENCE 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The $17,150.74 firm fixed price delivery order has a completion date of March 18, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not designated as a set-aside. This delivery order is part...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $17,150.74 firm fixed-price contract is for the supply of 4564313869 - CALQUENCE 100 MG TABLET 60S, with a period of performance through May 8, 2024. This order is placed under Amerisourcebergen's $999,999,999.00 single-award...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $34,301.44 by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of CALQUENCE 100 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCSBKDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award, valued at $8,575.36, has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 9/16/24, 10:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 6/17/24 |